Acumen Pharmaceuticals, Inc. (ABOS) Stock Ticker
ABOS right now
Market factors today
Unlock the full ABOS picture
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
ABOS stock facts
| Ticker symbol | ABOS |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $161.8M |
| CEO | Daniel J. O'Connell |
| Employees | 61 |
| Headquarters | Newton, MA, US |
| IPO date | 2021-07-01 |
| Website | acumenpharm.com |
What you can see for ABOS on Tickr
Live ABOS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ABOS report.
Rankings
FAQ
What is the ticker symbol for Acumen Pharmaceuticals, Inc.?
The ticker symbol for Acumen Pharmaceuticals, Inc. is ABOS, listed on the NASDAQ Global Select.
What is ABOS?
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in…